What is LATANOPROST OPHTHALMIC SOLUTION used for?

LATANOPROST OPHTHALMIC SOLUTION (brand name Latanoprost Ophthalmic Solution) is a Glaucoma Agent indicated for See full prescribing information.

How does LATANOPROST OPHTHALMIC SOLUTION work?

LATANOPROST OPHTHALMIC SOLUTION works through the following mechanism: Other agent.

What are the most common side effects of LATANOPROST OPHTHALMIC SOLUTION?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for LATANOPROST OPHTHALMIC SOLUTION. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is LATANOPROST OPHTHALMIC SOLUTION the same as Latanoprost Ophthalmic Solution?

Latanoprost Ophthalmic Solution is a brand name for LATANOPROST OPHTHALMIC SOLUTION. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

LATANOPROST OPHTHALMIC SOLUTION

Glaucoma Agent

Brand names: Latanoprost Ophthalmic Solution

Ophthalmic

Mechanism of Action

Other agent

Indications

See full prescribing information

Contraindications

• 4 CONTRAINDICATIONS Known hypersensitivity to latanoprost
• benzalkonium chloride
• or any other ingredients in this product. Known hypersensitivity to latanoprost
• benzalkonium chloride
• or any other ingredients in this product. (4)

FDA Warnings

5 WARNINGS AND PRECAUTIONS Pigmentation : Pigmentation of the iris, periorbital tissue (eyelid) and eyelashes can occur
Latanoprost ophthalmic solution should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Known Side Effects

8 documented side effects by frequency

Drug Not Working

>10%

Fatigue

1-10%

Headache

1-10%

Shortness of Breath

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Community Discussions

No community discussions found for LATANOPROST OPHTHALMIC SOLUTION yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → LATANOPROST OPHTHALMIC SOLUTION openFDA label JSON → LATANOPROST OPHTHALMIC SOLUTION FAERS adverse-event reports → LATANOPROST OPHTHALMIC SOLUTION ClinicalTrials.gov → completed Phase 2+ trials of LATANOPROST OPHTHALMIC SOLUTION

Compare With

15 available comparisons

Formulations

Dosage Forms

Tablet

Route

Ophthalmic